The Heterozygous Familial Hypercholesterolemia (HeFH) Management Market shows diverse growth potential across global regions. Developed nations, particularly in North America and Western Europe, have established robust healthcare infrastructures supporting early diagnosis and advanced treatment availability. However, developing economies are now emerging as lucrative growth territories....